Identity, Access Management & Biometric Solutions Provider BIO-key International Hosts Q4 Investor Call Thursday, March 27th at 10am ET
BIO-key International (NASDAQ: BKYI), a provider of Identity and Access Management and Identity-Bound Biometric solutions, has scheduled its Q4 2024 earnings conference call for Thursday, March 27th, 2025, at 10:00 AM ET. The company will release its financial results before the market opens on the same day.
The conference call will feature a presentation and Q&A session led by Chairman & CEO Mike DePasquale and CFO Cecilia Welch. The event will provide investors with insights into the company's performance and strategic initiatives in the identity and access management sector.
BIO-key International (NASDAQ: BKYI), fornitore di soluzioni per la gestione dell'identità e degli accessi e di soluzioni biometriche legate all'identità, ha programmato la sua chiamata per la conferenza sugli utili del Q4 2024 per giovedì 27 marzo 2025, alle 10:00 AM ET. L'azienda rilascerà i suoi risultati finanziari prima dell'apertura del mercato lo stesso giorno.
La chiamata per la conferenza includerà una presentazione e una sessione di domande e risposte guidata dal Presidente e CEO Mike DePasquale e dal CFO Cecilia Welch. L'evento fornirà agli investitori informazioni sulle prestazioni dell'azienda e sulle iniziative strategiche nel settore della gestione dell'identità e degli accessi.
BIO-key International (NASDAQ: BKYI), proveedor de soluciones de gestión de identidad y acceso, así como de soluciones biométricas vinculadas a la identidad, ha programado su llamada de conferencia sobre resultados del Q4 2024 para jueves 27 de marzo de 2025, a las 10:00 AM ET. La empresa publicará sus resultados financieros antes de la apertura del mercado ese mismo día.
La llamada de conferencia contará con una presentación y una sesión de preguntas y respuestas liderada por el Presidente y CEO Mike DePasquale y la CFO Cecilia Welch. El evento proporcionará a los inversores información sobre el rendimiento de la empresa y las iniciativas estratégicas en el sector de la gestión de identidad y acceso.
BIO-key International (NASDAQ: BKYI), 신원 및 접근 관리와 신원 기반 생체 인식 솔루션 제공업체,은 2024년 4분기 실적 컨퍼런스 콜을 2025년 3월 27일 목요일, 오전 10시(ET)에 예정했습니다. 회사는 같은 날 시장 개장 전 재무 결과를 발표할 예정입니다.
컨퍼런스 콜에서는 회장 겸 CEO인 Mike DePasquale와 CFO인 Cecilia Welch가 이끄는 발표와 질의응답 세션이 진행됩니다. 이 이벤트는 투자자들에게 신원 및 접근 관리 분야에서 회사의 성과와 전략적 이니셔티브에 대한 통찰력을 제공할 것입니다.
BIO-key International (NASDAQ: BKYI), fournisseur de solutions de gestion des identités et des accès ainsi que de solutions biométriques liées à l'identité, a programmé sa conférence téléphonique sur les résultats du T4 2024 pour jeudi 27 mars 2025, à 10h00 ET. L'entreprise publiera ses résultats financiers avant l'ouverture du marché le même jour.
La conférence téléphonique comprendra une présentation et une session de questions-réponses dirigée par le Président et CEO Mike DePasquale et la CFO Cecilia Welch. L'événement fournira aux investisseurs des informations sur la performance de l'entreprise et les initiatives stratégiques dans le secteur de la gestion des identités et des accès.
BIO-key International (NASDAQ: BKYI), Anbieter von Identitäts- und Zugriffsmanagement sowie identitätsgebundenen biometrischen Lösungen, hat seine Q4 2024 Ergebnis-Konferenzschaltung für Donnerstag, den 27. März 2025, um 10:00 Uhr ET angesetzt. Das Unternehmen wird die finanziellen Ergebnisse am selben Tag vor Markteröffnung veröffentlichen.
Die Konferenzschaltung wird eine Präsentation und eine Q&A-Session unter der Leitung von Chairman & CEO Mike DePasquale und CFO Cecilia Welch umfassen. Die Veranstaltung wird den Investoren Einblicke in die Unternehmensleistung und strategische Initiativen im Bereich Identitäts- und Zugriffsmanagement geben.
- None.
- None.
HOLMDEL, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q4 2024 investor call Thursday, March 27th at 10 a.m. ET. Results will be released before the market opens on Thursday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session.
| Conference Call Details | |
| Date / Time: | Thursday, March 27th at 10 a.m. ET |
| Call Dial In #: | 1-877-418-5460 U.S. or 1-412-717-9594 Int’l |
| Live Webcast / Replay: | Webcast & Replay Link – Available for 3 months. |
| Audio Replay: | 1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 6747311 |
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
| Engage with BIO-key | |
| Facebook – Corporate: | https://www.facebook.com/BIOkeyInternational/ |
| LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international |
| X – Corporate: | @BIOkeyIntl |
| X – Investors: | @BIO_keyIR |
| StockTwits: | BIO_keyIR |
Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
FAQ
When is BIO-key's (BKYI) Q4 2024 earnings call scheduled?
What time will BKYI release its Q4 2024 financial results?
Who will lead BIO-key's (BKYI) Q4 2024 earnings call?
What type of solutions does BIO-key (BKYI) provide?
